Antifragile therapy
J. West, B. Desai, M. Strobl, L. Pierik, R. Vander Velde, C. Armagost, R. Miles, M. Robertson-Tessi, A. Marusyk, A. R. A. Anderson
This paper introduces a mathematical framework to quantify cancer cell line fragility or antifragility to treatment variability and applies it to treatment resistance and collateral sensitivity.
bioRxiv · Oct 8, 2020 · PreprintCancer Biology